Orelabrutinib-bruton tyrosine kinase inhibitor-based regimens in the treatment of central nervous system lymphoma: a retrospective study

Jingjing Wu, Wenhua Wang, Meng Dong, Shanshan Ma, Xudong Zhang, Linan Zhu, Songtao Niu, Mengjie Ding, Jieming Zhang, Lei Zhang, Xin Li, Ling Li, Zhenchang Sun, Xinhua Wang, Xiaorui Fu, Zhaoming Li, Yu Chang, Feifei Nan, Jiaqin Yan, Hui Yu, Xiaolong Wu, Zhi‐Yuan Zhou, Mingzhi Zhang